NMPA accepts clinical trial application for monkeypox vaccine

chinadaily.com.cn | Updated: 2023-07-14 19:44

Share - WeChat

The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.

Photo

Nearly 70% of winter wheat sowed across China

Cultivation in Yunnan paves the way for 'durian freedom'

Winter scenery across China

Historic games cycling race a testament to GBA integration

Lhasa's GDP grows 7.1 percent in first three quarters of 2025

Scholars call for ecological protection of Tunbu culture

Latest

State Council News

China’s public holidays for 2026

Exclusive

HK, Taiwan volunteers share their passion at games' opening

Co-hosting games boosts GBA integration

Audiences amazed by National Games opening

Newsmaker

Chinese student in New York reimagines Miao embroidery with digital art

Transport aircraft pilot flies high in PLA

Ten photos you don't wanna miss

Ten photos from across China: Oct 31 - Nov 6

Special Coverage

4th Plenary Session of the 20th CPC Central Committee

Celebrating 70 years of progress in Xinjiang

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349

好看的中文字幕av,巨尻av在线,亚洲网视频,逼特视频,伊人久久综合一区二区,可以直接观看的av网站,天堂中文资源在线观看

NMPA accepts clinical trial application for monkeypox vaccine